Oxidative Damage, Platelet Activation, and Inflammation to Predict Mobility Disability and Mortality in Older Persons: Results From the Health Aging and Body Composition Study
Open Access
- 1 March 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 67A (6) , 671-676
Abstract
Inflammation, oxidative damage, and platelet activation are hypothesized biological mechanisms driving the disablement process. The aim of the present study is to assess whether biomarkers representing these mechanisms predicted major adverse health-related events in older persons. Data are from 2,234 community-dwelling nondisabled older persons enrolled in the Health Aging and Body Composition study. Biomarkers of lipid peroxidation (ie, urinary levels of 8-iso-prostaglandin F2α), platelet activation (ie, urinary levels of 11-dehydro-thromboxane B2), and inflammation (serum concentrations of interleukin-6) were considered as independent variables of interest and tested in Cox proportional hazard models as predictors of (severe) mobility disability and overall mortality. The sample’s (women 48.0%, whites 64.3%) mean age was 74.6 (SD 2.9) years. During the follow-up (median 11.4 years), 792 (35.5%), 269 (12.0%), and 942 (42.2%) events of mobility disability, severe mobility disability, and mortality occurred, respectively. Only interleukin-6 showed significant independent associations with the onset of all the study outcomes. Higher levels of urinary 8-iso-prostaglandin F2α and 11-dehydro-thromboxane B2 independently predicted increased risk of death (hazard ratio 1.10, 95% confidence interval 1.03–1.19 and hazard ratio 1.14, 95% confidence interval 1.06–1.23, respectively). No significant interactions of gender, race, cardiovascular disease, diabetes, and antiplatelet drugs were detected on the studied relationships. The inflammatory marker interleukin-6 is confirmed to be a robust predictor for the onset of negative health-related events. Participants with higher urinary levels of 8-iso-prostaglandin F2α and 11-dehydro-thromboxane B2 presented a higher mortality risk.Keywords
This publication has 43 references indexed in Scilit:
- Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular diseaseBiomarkers, 2008
- Oxidative Stress and Severe Walking Disability among Older WomenThe American Journal of Medicine, 2007
- Oxidative Stress Is Associated with Greater Mortality in Older Women Living in the CommunityJournal of the American Geriatrics Society, 2007
- Oxidative Damage and Platelet Activation as New Predictors of Mobility Disability and Mortality in EldersAntioxidants & Redox Signaling, 2006
- Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesisTrends in Pharmacological Sciences, 2005
- Isoprostanes and other markers of peroxidation in atherosclerosisBiomarkers, 2005
- Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes MellitusCirculation, 2003
- Compendium of Physical Activities: classification of energy costs of human physical activitiesMedicine & Science in Sports & Exercise, 1993
- The cardiovascular health study: Design and rationaleAnnals of Epidemiology, 1991
- Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1987